Weekly Nephrology/Health IT News Roundup :: April 19, 2012

More Physicians Awarded Meaningful Use Money
However, a MedPAC report notes that most doctors have not yet become eligible to earn bonuses for using electronic health records.

 

Deadline Extended for Appealing Medicare EHR Bonus
Physicians who believe they were incorrectly denied a Medicare bonus for using an electronic health record (EHR) system last year have a few more weeks to appeal their case.

 

Search Is on to Cure EHR Alert Fatigue
Researchers, physicians and others are coming up with strategies to ensure that warning alerts generated by health IT systems are less frequent — and more meaningful.

 

5 Steps to Transform EHRs into Modern Patient Collaboration Tools
With the rise of accountable care organizations (ACOs) and patient-centered medical homes (PCMH), the spotlight has been put on IT to help make a smoother transition to those new care models.

 

Value of Screening for Kidney Disease Unclear
Screening people to catch early kidney disease may sound like a good idea, but there is no research to prove that it’s worthwhile, according to a new review.

 

A Common Cholesterol Medication May Impact Kidney Health
Recent evidence from clinical trials and case reports suggests fibrates can cause an increase to serum creatinine, an indicator of kidney health measured by a blood test, which indicates a loss of kidney health.

 

CMS Gives Affymax’s Omontys Special Reimbursement Code
Affymax Inc. and Takeda Pharmaceuticals said Friday that the Centers for Medicare & Medicaid Services created a special reimbursement code, a Q-code, for their new anemia drug Omontys.

Comment on Article

*